Canary Global Approved for Canada’s SR&ED Program for Advancing Science and Technology
Canary Global has been accepted into Canada’s SR&ED program which aims to encourage R&D work conducted for the advancement of...
CEO & President, Founder
Senior Vice-President - Corporate Affairs & Partnerships, Co-Founder
Senior Scientific Advisor, Gene Therapy and Rare Diseases
Head Scientist
Senior Medical Advisor, Neurological Disorders, Parkinson’s Disease
View DetailsSenior Medical Advisor, Neurological Disorders, Parkinson’s Disease
Senior Scientific and Medical advisor , Rare Neurological Disease
Senior Scientific and Medical advisor , Rare Neurological Disease
MD Senior Medical Advisor
Canary Global has been accepted into Canada’s SR&ED program which aims to encourage R&D work conducted for the advancement of...
Rapid molecular PCR-like accurate saliva-based test delivers 95% sensitivity and 98% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including...
Non-invasive ultra-rapid test delivers 98% sensitivity and 100% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including variants Designed for...